Chargement en cours...
Antithrombin III is probably not a suitable biomarker for diagnosis of primary central nervous system lymphoma
Antithrombin III (AT III) in cerebrospinal fluid (CSF) has been suggested to have high specificity and sensitivity in separating primary central nervous system (CNS) lymphoma from other neurological conditions. We measured with ELISA CSF and serum AT III and albumin levels in 12 lymphoma patients wi...
Enregistré dans:
| Publié dans: | Ann Hematol |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer Berlin Heidelberg
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4432105/ https://ncbi.nlm.nih.gov/pubmed/25697593 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-015-2334-y |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|